| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 7.602 | 8.304 | 12.525 | 16.036 | 25.967 | 24.788 | 28.277 |
| Total Income - EUR | - | - | - | 7.637 | 8.339 | 12.567 | 16.090 | 30.219 | 25.799 | 28.277 |
| Total Expenses - EUR | - | - | - | 1.609 | 620 | 369 | 1.068 | 1.383 | 13.719 | 12.769 |
| Gross Profit/Loss - EUR | - | - | - | 6.028 | 7.719 | 12.197 | 15.022 | 28.837 | 12.080 | 15.508 |
| Net Profit/Loss - EUR | - | - | - | 5.815 | 7.470 | 11.820 | 14.540 | 27.930 | 9.719 | 12.876 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Ideal Doc-Asig Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 5.652 | 7.165 | 21.212 |
| Current Assets | - | - | - | 6.592 | 13.909 | 26.090 | 39.849 | 34.494 | 44.226 | 55.346 |
| Inventories | - | - | - | 608 | 596 | 585 | 0 | 0 | 40 | 1.589 |
| Receivables | - | - | - | 4.083 | 13.065 | 21.100 | 19.490 | 691 | 1.699 | 1.690 |
| Cash | - | - | - | 1.901 | 247 | 4.405 | 20.358 | 33.804 | 42.486 | 52.067 |
| Shareholders Funds | - | - | - | 6.059 | 13.411 | 24.977 | 38.963 | 37.611 | 47.216 | 59.829 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 533 | 497 | 1.113 | 885 | 2.535 | 4.174 | 16.730 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6622 - 6622" | |||||||||
| CAEN Financial Year |
6622
|
|||||||||
Comments - Ideal Doc-Asig Srl